Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2024
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Parcel Pick Up
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Aurinia Pharmaceuticals Inc.
< Previous
1
2
3
4
Next >
Aurinia Presents Results from the Two-Year AURORA 2 Continuation Study at the 2022 European Renal Association (ERA) Congress
May 20, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals Announces Presentations at the 2022 ERA Congress and the 2022 EULAR Congress
May 16, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Reports First Quarter 2022 Financial and Operational Results
May 10, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Notice of New Dial-In Numbers for Aurinia Pharmaceuticals First Quarter 2022 Financial and Operational Results on May 10, 2022
May 06, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals to Release First Quarter 2022 Financial and Operational Results on May 10, 2022
May 02, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Announces Year-Two Commitment to Patient Navigation Grant Program to Address Barriers for Individuals Living with Lupus and Lupus Nephritis
April 19, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals Announces Presentations at the 2022 National Kidney Foundation Spring Clinical Meetings
April 04, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Reports Fourth Quarter and Full Year 2021 Financial Results and Company Updates
February 28, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2021 Financial Results on February 28, 2021
February 09, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals to Present at the 11th Annual Leerink Global Healthcare Conference
February 03, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals to Present at Upcoming January Investor Conferences
January 04, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)
December 09, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference
November 10, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates
November 03, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis
November 01, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021
October 27, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021
October 26, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences
September 15, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
September 10, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases
August 17, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotech Conference
August 09, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
August 05, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals to Release Second Quarter 2021 Financial Results on August 5, 2021
July 26, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange
July 16, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Awards $250,000 in Grants to Support Patient Navigation Programs
June 30, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Announces Licensing Partner Otsuka Filed Initial Marketing Authorization Application (MAA) for Voclosporin with the European Medicines Agency (EMA)
June 25, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors
June 14, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Announces Results of the 2021 Annual General Meeting
June 07, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Announces Additional Analysis of its AURORA 1 Phase 3 Study Data Presented at ERA-EDTA 2021 Congress
June 07, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
May 27, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Tickers
AUPH
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.